Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Mar;196(3):169-77.
doi: 10.1007/s00203-014-0952-8. Epub 2014 Jan 31.

Morphological changes in Proteus mirabilis O18 biofilm under the influence of a urease inhibitor and a homoserine lactone derivative

Affiliations

Morphological changes in Proteus mirabilis O18 biofilm under the influence of a urease inhibitor and a homoserine lactone derivative

Grzegorz Czerwonka et al. Arch Microbiol. 2014 Mar.

Abstract

Proteus mirabilis is a pathogenic gram-negative bacterium that frequently causes kidney infections, typically established by ascending colonization of the urinary tract. The present study is focused on ureolytic activity and urease inhibition in biofilms generated by P. mirabilis O18 cells. Confocal microscopy revealed morphological alterations in biofilms treated with urea and a urease inhibitor (acetohydroxamic acid, AHA), as some swarmer cells were found to protrude from the biofilm. The presence of a quorum-sensing molecule (N-butanoyl homoserine lactone, BHL) increased biofilm thickness and its ureolytic activity. Laser interferometric determination of diffusion showed that urea easily diffuses through P. mirabilis biofilm, while AHA is blocked. This may suggest that the use of urease inhibitors in CAUTIs may by less effective than in other urease-associated infections. Spectroscopic studies revealed differences between biofilm and planktonic cells indicating that polysaccharides and nucleic acids are involved in extracellular matrix and biofilm formation.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Proteus mirabilis O18 pDsRed2 biofilm stained with live/dead BacLight stain (Invitrogen), 72-h culture. a Stacked images, b live cells, c dead cells
Fig. 2
Fig. 2
Morphological changes in Proteus mirabilis O18 pDsRed2 biofilm after treatment with AHA (a), urea (b), and both (c). Images acquired with a Leica confocal microscope. Scale bar 5 μm
Fig. 3
Fig. 3
Swarming motility of Proteus mirabilis O18 pDsRed in a test plate with LB agar (1 %, w/v) supplemented with AHA (200 μg/mL)
Fig. 4
Fig. 4
Determination of planktonic cells (absorbance at 550 nm) and biofilm mass (crystal violet method, absorbance at 595 nm) for Proteus mirabilis O18 pDsRed strain in increasing concentration of AHA
Fig. 5
Fig. 5
Kinetics of ureolytic activity of Proteus mirabilis O18 biofilms treated with 10 nM BHL and control
Fig. 6
Fig. 6
A nucleopore membrane covered with Proteus mirabilis O18 biofilm. a Membrane surface—light passing through a membrane with round pores, b live Proteus mirabilis cells on the membrane surface, c biofilm stained for dead cells. Live/dead staining was performed with FilmTracer™ dyes (Invitrogen). The images were obtained using a Carl Zeiss Axio Scope.A1 epifluorescent microscope
Fig. 7
Fig. 7
Biofilm area coverage of CV-stained membranes. Gray levels from 1 (black) to 256 (white) represent the levels of coverage, where high numbers correspond to low coverage, and low numbers to high coverage
Fig. 8
Fig. 8
Interferometric analysis of the acetohydroxamic acid (AHA) and urea released from the lower cuvette through a Proteus mirabilis O18 biofilm attached to nucleopore membranes at room temperature measured with a laser interferometric system. Representative results are presented. The initial concentration of both substances was 250 μg/mL
Fig. 9
Fig. 9
Scheme visualizing the obtained data. The addition of 10 nM BHL increased both biofilm thickness and its ureolytic activity. Diffusion of the urease inhibitor is blocked, while urea diffuses freely. Starvation conditions may induce the presence of protruding swarmer cells. Biofilm mass tightly covers the nucleopore membrane
Fig. 10
Fig. 10
Representative FT-IR spectra (4,000–800 cm−1) of Proteus mirabilis planktonic cells (a), Proteus mirabilis biofilm, (b) and a superposition of the above-mentioned cultures (c)

Similar articles

Cited by

  • Pathogenesis of Proteus mirabilis Infection.
    Armbruster CE, Mobley HLT, Pearson MM. Armbruster CE, et al. EcoSal Plus. 2018 Feb;8(1):10.1128/ecosalplus.ESP-0009-2017. doi: 10.1128/ecosalplus.ESP-0009-2017. EcoSal Plus. 2018. PMID: 29424333 Free PMC article. Review.
  • The role of Proteus mirabilis cell wall features in biofilm formation.
    Czerwonka G, Guzy A, Kałuża K, Grosicka M, Dańczuk M, Lechowicz Ł, Gmiter D, Kowalczyk P, Kaca W. Czerwonka G, et al. Arch Microbiol. 2016 Nov;198(9):877-84. doi: 10.1007/s00203-016-1249-x. Epub 2016 Jun 4. Arch Microbiol. 2016. PMID: 27262948 Free PMC article.

References

    1. Arabski M, Wasik S, Dworecki K, Kaca W. Laser interferometric and cultivation methods for measurement of colistin/ampicilin and saponin interactions with smooth and rough of Proteus mirabilis lipopolysaccharides and cells. J Microbiol Methods. 2009;77(2):178–183. doi: 10.1016/j.mimet.2009.01.020. - DOI - PubMed
    1. Arabski M, Wasik S, Drulis-Kawa Z, Grzeskiewicz H, Gubernator J, Kaca W (2012) Laser interferometric determination of liposomes diffusion through artificial membranes In: Interferometry–research and applications in science and technology. ISBN 978-953-51-0403-2, 2012
    1. Armbruster CE, Mobley HL. Merging mythology and morphology: the multifaceted lifestyle of Proteus mirabilis. Nat Rev Microbiol. 2012;10(11):743–754. doi: 10.1038/nrmicro2890. - DOI - PMC - PubMed
    1. Belas R, Schneider R, Melch M. Characterization of Proteus mirabilis precocious swarming mutants: identification of rsbA, encoding a regulator of swarming behavior. J Bacteriol. 1998;180:6126–6139. - PMC - PubMed
    1. Cartagena E, Colom OA, Neske A, Valdez JC, Bardón A. Effects of plant lactones on the production of biofilm of Pseudomonas aeruginosa. Chem Pharm Bull. 2007;55(1):22–25. doi: 10.1248/cpb.55.22. - DOI - PubMed

Publication types

MeSH terms